Nordic Science Investments

Solid IO is a biotechnology company specializing in organ-on-chip technology for oncology. It replicates the tumor microenvironment to provide real-time, patient-specific insights, enabling clinicians to make precise treatment decisions and accelerating immuno-oncology drug development.

Phenaros Pharmaceuticals is a Swedish spin-off drug discovery company from Uppsala University. We employ phenomics (large-scale cell morphological profiling) in conjunction with automation and AI to discover and repurpose medications for uncommon diseases. Aside from developing an in-house drug discovery pipeline, we also form collaborations to provide access to our discovery platform.

Acouspin is a technology company that specializes in AI-driven, ultrasonic-enhanced systems for efficient and flexible nanofiber production. Their innovative solution enables manufacturers to achieve precision in nanofiber production without requiring specific expertise. The technology addresses common challenges such as needle clogs, allows real-time adjustments to fiber diameters, and simplifies the manufacturing process, making it more accessible and efficient. This transformation opens up new possibilities for large-scale applications across various industries.

PrecisionPhage, based in Jyvaskyla, Finland, is a biotechnology company focused on bacteriophage technologies. It provides an online phage genome analysis tool and services including bioinformatic analyses, bacteriophage licensing, and laboratory services. These offerings enable healthcare firms to perform genome assembly, analysis, and comparison, as well as facilitate drug development research.

NADMED develops NAD measurement technology designed to quantify all four NAD forms and glutathione. Its metabolite extraction system uses a nondestructive extraction method and colorimetric quantification to enable precise analysis across diverse biological samples. The technology supports research and clinical applications by providing measuring kits for laboratories and laboratory services, with use cases spanning cells, liver, brain, muscle, and blood from human or animal origin. NADMED aims to support researchers and clinicians in studying NAD metabolism and redox biology through accessible, reliable measurement tools.

RNatives is a biotechnology company specializing in the development of innovative RNA-based therapies. It focuses on RNA activation, particularly targeting VEGFA for cardiovascular disease treatment. The company aims to advance its lead programs through rigorous research and development to offer novel therapeutic options for unmet medical needs.

AIATELLA is a company focused on revolutionizing cardiovascular diagnostics by utilizing artificial intelligence to automate the quantification, detection, and interpretation of medical images. Their advanced technology caters to various imaging modalities, aiming to enhance efficiency and ensure standardized analysis while supporting precision medicine. In response to the global challenges posed by a shortage of radiologists and the increasing prevalence of cardiovascular diseases, AIATELLA develops cloud-based medical software that equips healthcare professionals with AI systems designed to accurately detect and diagnose these conditions. By providing innovative tools, the company seeks to improve diagnostic accuracy and ultimately enhance patient outcomes in the healthcare sector.

Perfat Technologies is a health-focused technology company that develops innovative applications for managing fat content in foods using advanced techniques like ultrasound and oleogel technologies. Their mission is to provide consumers with healthier vegetable oil options, such as rapeseed or sunflower oil, by optimizing bioprocesses to enhance sustainability and reduce production costs.

RNatives is a biotechnology company specializing in the development of innovative RNA-based therapies. It focuses on RNA activation, particularly targeting VEGFA for cardiovascular disease treatment. The company aims to advance its lead programs through rigorous research and development to offer novel therapeutic options for unmet medical needs.